Kaili Huang
Chengdu, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Case Report: Long-term TCR repertoire dynamics in a disease-free survival stage IIIB-N3 lung adenocarcinoma patient treated with anti-PD-1 followed by surgery.
Journal: Frontiers in immunology
Published: March 23, 2026
Analysis of the feasibility and health-economics value of simultaneous bilateral pulmonary surgery.
Journal: Frontiers in surgery
Published: June 24, 2025
Respiratory emerging viruses and drug resistance in lung cancer: challenges and new perspectives in treatment.
Journal: Molecular aspects of medicine
Published: May 19, 2025
Case Report: Locally advanced lung adenocarcinoma with a novel MIR217HG-ALK rearrangement responding to neoadjuvant alectinib.
Journal: Frontiers in pharmacology
Published: March 30, 2025
Sleeve Lobectomy, Pulmonary Artery Plasty, and Superior Vena Cava Reconstruction for Locally Advanced Non-small Cell Lung Cancer: A Single-Center Retrospective Study.
Journal: Annals of surgical oncology
Published: February 21, 2025
Survival outcomes of radical surgery after induction chemoimmunotherapy in clinical stage IIIA-IIIB (N2) non-small cell lung cancer.
Journal: Chinese medical journal
Published: January 04, 2025
Influence of Cycles of Neoadjuvant Chemoimmunotherapy on Treatment Response in Stage IIIA-N2IIIB Non-small Cell Lung Cancer: Experience from a Large-Volume Center.
Journal: Annals of surgical oncology
Published: November 25, 2024
Case Report: A novel ELMOD3-ALK and EML4-ALK double-fusion responses to neoadjuvant alectinib in a lung adenocarcinoma patient.
Journal: Frontiers in pharmacology
Published: October 23, 2024
Case Report: A novel MET exon 14 skipping mutation after EGFR-TKI resistance in advanced lung adenocarcinoma and sustained clinical response to savolitinib.
Journal: Frontiers in pharmacology
Published: September 01, 2024
Late-onset chylothorax after lung cancer surgery: clinical characteristics, management, and prevention.
Journal: ANZ journal of surgery
Published: May 30, 2024
Coexistence of a novel intergenic (between CHST2 and SLC9A9)-ALK, TNIK-ALK double-fusion in resected lung adenocarcinoma.
Journal: Asian journal of surgery
Published: October 26, 2023
Complete pathological response and negative postoperative ctDNA were not predictive of discontinuation of adjuvant crizotinib therapy in a patient with locally advanced MET ex14 skipping mutation-positive non-small cell lung cancer: a case report.
Journal: Frontiers in oncology
Published: February 13, 2023
Last Updated: 09/26/2026